Cresco Labs Inc CRLBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CRLBF is a good fit for your portfolio.
News
-
Florida Supreme Court OKs adult-use cannabis referendum for November ballot in victory for pot companies
-
Cannabis stocks extend gains after Biden White House shows support of marijuana reforms
-
Cresco Labs' stock rallies as cannabis company swings to a profit
-
Cannabis stocks rise after President Biden mentions plant in State of the Union speech
-
Cannabis stocks rise as Germany takes 'first big step' toward broader legalization in Europe
-
Canadian cannabis giant Canopy Growth seeks shareholder approval to speed up entry into U.S. market
-
Cresco Labs Promotes Greg Butler to President
-
Curaleaf, Truelive, Verano could benefit from marijuana reclassification
Trading Information
- Previous Close Price
- $1.95
- Day Range
- $1.95–2.00
- 52-Week Range
- $1.00–2.77
- Bid/Ask
- $1.99 / $2.00
- Market Cap
- $679.42 Mil
- Volume/Avg
- 194,256 / 947,950
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.84
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,760
- Website
- https://www.crescolabs.com
Comparables
Valuation
|
Metric
|
CRLBF
|
VRNO
|
CURA
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 1.35 | 1.34 | 3.42 |
Price/Sales | 0.84 | 1.73 | 2.58 |
Price/Cash Flow | 15.02 | 14.80 | 60.94 |
Price/Earnings
CRLBF
VRNO
CURA
Financial Strength
|
Metric
|
CRLBF
|
VRNO
|
CURA
|
|---|---|---|---|
Quick Ratio | 0.78 | 0.52 | 0.31 |
Current Ratio | 1.39 | 0.96 | 0.85 |
Interest Coverage | −1.36 | 1.46 | −0.24 |
Quick Ratio
CRLBF
VRNO
CURA
Profitability
|
Metric
|
CRLBF
|
VRNO
|
CURA
|
|---|---|---|---|
Return on Assets (Normalized) | −3.12% | −2.28% | −3.72% |
Return on Equity (Normalized) | −8.02% | −4.10% | −10.45% |
Return on Invested Capital (Normalized) | −0.11% | −0.53% | −2.20% |
Return on Assets
CRLBF
VRNO
CURA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ctjgvnrjb | Npmrfx | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Lxxxcxzjr | Lbdww | $68.9 Bil | |
HLN
| Haleon PLC ADR | Ncbbhrrh | Pvqc | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nfcwzvyr | Hvfc | $14.8 Bil | |
VTRS
| Viatris Inc | Sxnnxjxb | Cmkdp | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pnlysglg | Zfx | $11.9 Bil | |
CTLT
| Catalent Inc | Wwsjwjl | Pyplzh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Hkvvjcjq | Cbnr | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Sqntvyjm | Qbv | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vyrkqgdx | Fpfqhv | $3.5 Bil |